Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | St6galnac5 | Rat | (+)-catechin | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:24763279 | St6galnac5 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:22079256 | St6galnac5 | Rat | 1,2-dichloroethane | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:28960355 | St6galnac5 | Rat | 17beta-estradiol | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Estradiol results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:19484750 | St6galnac5 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:18648102 | St6galnac5 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:28973697 | St6galnac5 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:28973697 | St6galnac5 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:24780913 and PMID:25825206 | St6galnac5 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:28959563 | St6galnac5 | Rat | acrylamide | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:32763439 | St6galnac5 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of ST6GALNAC5 intron | CTD | PMID:30157460 | St6galnac5 | Rat | all-trans-retinoic acid | increases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:18052213 | St6galnac5 | Rat | all-trans-retinoic acid | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:21934132 and PMID:23724009 | St6galnac5 | Rat | arsane | affects methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ST6GALNAC5 gene | CTD | PMID:25304211 | St6galnac5 | Rat | arsenic atom | affects methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ST6GALNAC5 gene | CTD | PMID:25304211 | St6galnac5 | Rat | arsenite(3-) | increases methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | arsenite results in increased methylation of ST6GALNAC5 promoter | CTD | PMID:23974009 | St6galnac5 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of ST6GALNAC5 gene | CTD | PMID:35440735 | St6galnac5 | Rat | benzene | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Benzene results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:15120971 and PMID:15122651 | St6galnac5 | Rat | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:21839799 | St6galnac5 | Rat | benzo[a]pyrene | increases methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ST6GALNAC5 3' UTR more ... | CTD | PMID:27901495 | St6galnac5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:25181051 | St6galnac5 | Rat | bisphenol A | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:32156529 | St6galnac5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:34947998 | St6galnac5 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ST6GALNAC5 gene | CTD | PMID:28505145 | St6galnac5 | Rat | carbamazepine | affects expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ST6GALNAC5 mRNA | CTD | PMID:25979313 | St6galnac5 | Rat | carbon nanotube | increases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:25554681 | St6galnac5 | Rat | CGP 52608 | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ST6GALNAC5 gene] | CTD | PMID:28238834 | St6galnac5 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:27523638 | St6galnac5 | Rat | DDE | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:38568856 | St6galnac5 | Rat | Didecyldimethylammonium | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | didecyldimethylammonium results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:32763356 | St6galnac5 | Rat | dorsomorphin | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | St6galnac5 | Rat | entinostat | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | entinostat results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:26272509 | St6galnac5 | Rat | entinostat | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:27188386 | St6galnac5 | Rat | ethanol | affects expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Ethanol affects the expression of ST6GALNAC5 mRNA | CTD | PMID:30319688 | St6galnac5 | Rat | folic acid | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:25629700 | St6galnac5 | Rat | fonofos | increases methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of ST6GALNAC5 promoter | CTD | PMID:22847954 | St6galnac5 | Rat | formaldehyde | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:20655997 | St6galnac5 | Rat | genistein | decreases expression | ISO | St6galnac5 (Mus musculus) | 6480464 | Genistein results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:32186404 | St6galnac5 | Rat | glyphosate | increases methylation | EXP | | 6480464 | Glyphosate results in increased methylation of ST6GALNAC5 gene | CTD | PMID:31011160 | St6galnac5 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of ST6GALNAC5 gene | CTD | PMID:35440735 | St6galnac5 | Rat | hydroquinone | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:31256213 | St6galnac5 | Rat | lipopolysaccharide | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:35811015 | St6galnac5 | Rat | maneb | multiple interactions | ISO | St6galnac5 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:36117858 | St6galnac5 | Rat | methotrexate | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:17379860 | St6galnac5 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of ST6GALNAC5 gene | CTD | PMID:35440735 | St6galnac5 | Rat | methylmercury chloride | increases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:28001369 | St6galnac5 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:24810058 | St6galnac5 | Rat | nickel atom | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Nickel results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:25583101 | St6galnac5 | Rat | panobinostat | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:26272509 | St6galnac5 | Rat | panobinostat | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:27188386 | St6galnac5 | Rat | paraquat | multiple interactions | ISO | St6galnac5 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:36117858 | St6galnac5 | Rat | parathion | increases methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Parathion results in increased methylation of ST6GALNAC5 promoter | CTD | PMID:22847954 | St6galnac5 | Rat | permethrin | increases expression | EXP | | 6480464 | Permethrin results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:19017407 | St6galnac5 | Rat | phenylmercury acetate | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:27188386 | St6galnac5 | Rat | potassium chromate | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:22079256 | St6galnac5 | Rat | potassium chromate | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:22079256 | St6galnac5 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:35811015 | St6galnac5 | Rat | SB 431542 | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | St6galnac5 | Rat | silicon dioxide | increases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:25351596 | St6galnac5 | Rat | sodium arsenite | affects methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of ST6GALNAC5 gene | CTD | PMID:28589171 | St6galnac5 | Rat | sunitinib | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:31533062 | St6galnac5 | Rat | terbufos | increases methylation | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | terbufos results in increased methylation of ST6GALNAC5 promoter | CTD | PMID:22847954 | St6galnac5 | Rat | trichostatin A | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:24935251 and PMID:26272509 | St6galnac5 | Rat | trichostatin A | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:27188386 | St6galnac5 | Rat | valproic acid | increases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ST6GALNAC5 mRNA | CTD | PMID:24935251 | St6galnac5 | Rat | valproic acid | affects expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ST6GALNAC5 mRNA | CTD | PMID:25979313 | St6galnac5 | Rat | valproic acid | decreases expression | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:23179753 more ... | St6galnac5 | Rat | valproic acid | multiple interactions | ISO | ST6GALNAC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GALNAC5 mRNA | CTD | PMID:27188386 | |